Stent Deployment in Old Saphenous Vein Grafts with the Use of a Protection Device
暂无分享,去创建一个
[1] W. O’Neill,et al. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. , 2001, Journal of the American College of Cardiology.
[2] S. Sdringola,et al. Percutaneous intervention in saphenous venous grafts: in-stent restenosis lesions are safer than de novo lesions. , 2001, The Journal of invasive cardiology.
[3] M. Kern,et al. The coronary no-reflow phenomenon: a review of mechanisms and therapies. , 2001, European heart journal.
[4] C. Vlachopoulos,et al. Stents covered by autologous venous grafts: feasibility and immediate and long-term results. , 2000, American heart journal.
[5] E. Topol,et al. Recognition of the importance of embolization in atherosclerotic vascular disease. , 2000, Circulation.
[6] O. Rosales,et al. Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no‐reflow phenomenon , 1999 .
[7] Katherine C. Wu,et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. , 1998, Circulation.
[8] O. Rosales,et al. Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon. , 1998, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[9] J. M. Bloom. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. , 1998, The New England journal of medicine.
[10] J. Dougherty,et al. Treatment of thrombotic saphenous vein bypass grafts using local urokinase infusion therapy with the Dispatch catheter. , 1997, Catheterization and cardiovascular diagnosis.
[11] E. Jones,et al. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. , 1997, Circulation.
[12] E. Topol,et al. The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures. , 1996, Circulation.
[13] D. Baim,et al. Editorial comment: Understanding the “no‐reflow” problem , 1996 .
[14] W J Keon,et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. , 1996, Journal of the American College of Cardiology.
[15] J. Tcheng. Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective. , 1996, The American journal of cardiology.
[16] M. Hori,et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.
[17] W. O’Neill,et al. Recanalization of Chronically Occluded Aortocoronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion of Urokinase (ROBUST): a serial trial. , 1996, Journal of the American College of Cardiology.
[18] D. Baim,et al. Understanding the "no-reflow" problem. , 1996, Catheterization and cardiovascular diagnosis.
[19] B. Chaitman,et al. Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. Coronary Artery Surgery Study. , 1995, Journal of the American College of Cardiology.
[20] D. Baim,et al. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. , 1994, Circulation.
[21] E. Jones,et al. Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. , 1994, The American journal of cardiology.
[22] W. Keon,et al. Coronary bypass graft fate: long-term angiographic study. , 1991, Journal of the American College of Cardiology.